I agree that this site is using cookies. You can find further informations here.
X
Facheris, Maurizio
70  results:
Search for persons X
?
1

Foslevodopa/foscarbidopa Subcutaneous Infusion Maintains Si..:

Rosebraugh, Matthew ; Facheris, Maurizio
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
2

Comparability of Foslevodopa/Foscarbidopa Pharmacokinetics ..:

Rosebraugh, Matthew ; Neenan, Melina ; Facheris, Maurizio
Clinical Pharmacology in Drug Development.  12 (2022)  4 - p. 407-415 , 2022
Link: https://doi.org/10.1002/..
 
?
3

Safety and Efficacy of 24-Hour/Day Subcutaneous Infusion of..:

Aldred, Jason ; Bergmans, Bruno ; Carroll, Camille...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
4

Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral..:

Facheris, Maurizio ; Robieson, Weining ; Fisseha, Nahome.
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
5

Foslevodopa/foscarbidopa subcutaneous infusion maintains eq..:

Rosebraugh, Matthew ; Stodtmann, Sven ; Liu, Wei.
Journal of the Neurological Sciences.  429 (2021)  - p. 119570 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Efficacy and safety of foslevodopa/foscarbidopa versus oral..:

Facheris, Maurizio ; Robieson, Weining ; Fisseha, Nahome.
Journal of the Neurological Sciences.  429 (2021)  - p. 119569 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Foslevodopa/foscarbidopa Subcutaneous Infusion Maintains Eq..:

Rosebraugh, Matthew ; Stodtmann, Sven ; Liu, Wei.
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
8

Safety and Tolerability in Parkinson's Disease Patients Tre..:

Facheris, Maurizio ; Benesh, Janet ; Streit, Janet...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
9

Safety and Tolerability During a 4-Week Continuous Subcutan..:

Facheris, Maurizio ; Criswell, Susan ; Pavasia, Nirav...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
10

ABBV-951 Maintains Stable Levodopa Exposure following Subcu..:

Rosebraugh, Matthew ; Kym, Philip ; Liu, Wei.
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
11

A Novel Levodopa/Carbidopa Prodrug (ABBV-951) 24-Hour Conti..:

Rosebraugh, Matthew ; Kym, Philip ; Liu, Wei..
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
12

Critical Path for Parkinson's: Catalyzing Innovation for Pa..:

Stephenson, Diane ; Akalu, Mussie ; Alexander, Robert...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
13

Rationale and Design of an Open-Label, Randomized, 26-Week ..:

Chaudhuri, K. Ray ; Weintraub, Daniel ; Antonini, Angelo...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
14

Improvement in Attention/Memory Domains in Advanced Parkins..:

Standaert, David ; Rodriguez, Ramon ; Slevin, John...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
15

The prodromal phase of leucine-rich repeat kinase 2-associa..:

Pont-Sunyer, Claustre ; Tolosa, Eduardo ; Caspell-Garcia, Chelsea...
Movement Disorders.  32 (2017)  5 - p. 726-738 , 2017
Link: https://doi.org/10.1002/..
 
1-15